On April 1, the Government of India announced comprehensive guidelines concerning the usage, risks, and regulation of GLP-1 (glucagon-like peptide-1) drugs. These medications are primarily designed to assist individuals with diabetes, specifically targeting type 2 diabetes,...
The Drugs Controller General of India (DCGI) has issued an alert regarding the theft of a specific batch of Sanofi India's insulin product, Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL). The affected batch,...
Bangalore, India: Co-founder Nick Jonas, board member Priyanka Chopra Jonas and Beyond Type 1 today launch #TheBeyondType in India. Nick Jonas, who was diagnosed...
Prayagraj, India: Underscoring their commitment to combating diabetes-led vision impairment, the Eyebetes Foundation, led by renowned Mumbai-based eye surgeon Dr. Nishant Kumar (a three-time...
Mumbai, India: As global mobility surges, managing chronic conditions like diabetes during travel has become a significant concern. Diabetes remains one of the fastest-growing...
Mumbai, India: Fitterfly, a leading health-tech company specializing in digital therapeutics (DTx), has released insightful data from the analysis of approximately 16,000 digital interactions...
